AthGene - Exit in 2017

🗓 Founded 2015👥 1 employees💰 Last funded May 2016
Sold to Nordic Group AthGene is on a mission to help change the way people think about their diet and fitness by providing the public with access to interpretations of their specific gene variants, so that they may be better informed as to how they can more efficiently try to lead a healthy and balanced lifestyle. A problem for most fitness enthusiasts is their inability to design a lifestyle that includes appropriate meals and exercises, as they have to always second guess their chosen diets and exercise routines. Many rely heavily on the advice of “social media wellness gurus”, but this is not suited to the individual’s genetic setup and dietary needs. And this is where AthGene comes in. AthGene will help people clarify what to eat in order to optimise their fitness training and subsequently improving their wellness.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2015
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Arab Emirates
1
Frequently asked questions
Who invested in AthGene - Exit in 2017?
AthGene - Exit in 2017 has 1 investors on record on gritt.io, including 1 early-stage backers.
When did AthGene - Exit in 2017 last raise funding?
The most recent investment in AthGene - Exit in 2017 recorded on gritt.io was in May 2016.
When was AthGene - Exit in 2017 founded?
AthGene - Exit in 2017 was founded in 2015.
What industry is AthGene - Exit in 2017 in?
AthGene - Exit in 2017 operates in Wellness and Fitness Services. Find similar Wellness and Fitness Services investors on gritt.io.
Where is AthGene - Exit in 2017 based?
AthGene - Exit in 2017 is headquartered in Kopenhagen.